PeptideDB

I-BRD9 1714146-59-4

I-BRD9 1714146-59-4

CAS No.: 1714146-59-4

I-BRD9 is a BRD9 specific inhibitor, identified by scientists at GlaxoSmithKline. I-BRD9 is a potent and selective binde
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

I-BRD9 is a BRD9 specific inhibitor, identified by scientists at GlaxoSmithKline. I-BRD9 is a potent and selective binder to BRD9 with a pIC50 in a Time-Resolved FRET assay of 7.3. BRD4 was used as a representative member of the BET family for initial selectivity screening, I-BRD9 displayed a pIC50 of 5.3 against this protein. (//www.thesgc.org/chemical-probes/I-BRD9)



Physicochemical Properties


Molecular Formula C22H22F3N3O3S2
Molecular Weight 497.5512
Exact Mass 497.105
CAS # 1714146-59-4
Related CAS # 1714146-59-4;
PubChem CID 91668541
Appearance White to off-white solid powder
Density 1.5±0.1 g/cm3
Boiling Point 721.0±70.0 °C at 760 mmHg
Flash Point 389.9±35.7 °C
Vapour Pressure 0.0±2.3 mmHg at 25°C
Index of Refraction 1.655
LogP 2.18
Hydrogen Bond Donor Count 1
Hydrogen Bond Acceptor Count 8
Rotatable Bond Count 4
Heavy Atom Count 33
Complexity 915
Defined Atom Stereocenter Count 0
InChi Key YQYSVMKCMIUCHY-WJOKGBTCSA-N
InChi Code

InChI=1S/C37H48N4O4S/c1-26-9-10-30-23-33(46-32(30)21-26)35(43)40-37(15-5-6-16-37)36(44)39-31(22-27-7-3-2-4-8-27)34(42)38-24-28-11-17-41(18-12-28)25-29-13-19-45-20-14-29/h2-4,7-10,21,23,28-29,31H,5-6,11-20,22,24-25H2,1H3,(H,38,42)(H,39,44)(H,40,43)/t31-/m1/s1
Chemical Name

5-ethyl-4,5-dihydro-4-oxo-N-(tetrahydro-1,1-dioxido-2H-thiopyran-4-yl)-7-[3-(trifluoromethyl)phenyl]-thieno[3,2-c]pyridine-2-carboximidamide
Synonyms

I-BRD9 I-BRD-9 I-BRD 9
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vitro I-BRD9 (10 μM, 6 hours) regulates immunological pathways and cancer [1]. I-BRD9 (10 μM) exhibits exceptional wider bromodomain selectivity together with robust BRD9 affinity [1]. I-BRD9 (10 μM) exhibits affinity with pIC50 values of 7.3 μM, 5.3 μM, and 6.8 μM for BRD9 (TR-FRET), BRD4 BD1 (TR-FRET), and BRD9 NanoBRET [1]. The high water solubility (CLND) of 359 μM is exhibited by I-BRD9 (10 μM)[1]. In HUT-78 cell lysates, I-BRD9 (10 μM) exhibits >625-fold selectivity for binding to endogenous BRD9 (versus BET family member BRD3) [1].
Cell Assay RT-PCR[1]
Cell Types: Kasumi-1 Cell
Tested Concentrations: 10 μM
Incubation Duration: 6 hrs (hours)
Experimental Results: demonstrated that 4 genes (CLEC1, 62 DUSP6, 63 FES64 and SAMSN165) were strongly down-regulated and not affected by I-BET151.
References

[1]. Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition. J Med Chem.


Solubility Data


Solubility (In Vitro) DMSO : ~13.89 mg/mL (~27.92 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 1.39 mg/mL (2.79 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 13.9 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 1.39 mg/mL (2.79 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 13.9 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 3: ≥ 1.39 mg/mL (2.79 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 13.9 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.0098 mL 10.0492 mL 20.0985 mL
5 mM 0.4020 mL 2.0098 mL 4.0197 mL
10 mM 0.2010 mL 1.0049 mL 2.0098 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.